Cytoreductive Surgery for Peritoneal Malignancies-Development of Standards of Care for the Community

Jesus Esquivel

Research output: Contribution to journalReview articlepeer-review

Abstract

Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC) continue to play an increasing role in the management of peritoneal surface malignancies of gastrointestinal origin. The prognosis of patients and the responses to cytoreductive surgery and HIPEC depend on the histology, the degree of malignant transformation, the adequacy of the cytoreductive surgery, and the response to systemic therapy. Continuous interaction between medical and surgical oncologists is needed to identify the most appropriate patients for and the most efficient sequence of the available therapeutic modalities.

Original languageEnglish (US)
Pages (from-to)653-666
Number of pages14
JournalSurgical Oncology Clinics of North America
Volume16
Issue number3
DOIs
StatePublished - Jul 1 2007

ASJC Scopus subject areas

  • Surgery
  • Oncology

Fingerprint Dive into the research topics of 'Cytoreductive Surgery for Peritoneal Malignancies-Development of Standards of Care for the Community'. Together they form a unique fingerprint.

Cite this